The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(6-methoxy-3,4-dihydroquinolin-1(2H)-yl)-1-(4-o-tolylpiperazin-1-yl)propan-1-one ID: ALA4540163
PubChem CID: 121596739
Max Phase: Preclinical
Molecular Formula: C24H31N3O2
Molecular Weight: 393.53
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc2c(c1)CCCN2CCC(=O)N1CCN(c2ccccc2C)CC1
Standard InChI: InChI=1S/C24H31N3O2/c1-19-6-3-4-8-22(19)26-14-16-27(17-15-26)24(28)11-13-25-12-5-7-20-18-21(29-2)9-10-23(20)25/h3-4,6,8-10,18H,5,7,11-17H2,1-2H3
Standard InChI Key: QQGCAGRRBJCDSP-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
15.7398 -16.6203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7387 -17.4398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1536 -16.6167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4449 -16.2115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1564 -17.4394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4472 -17.8437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4428 -18.6556 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1459 -19.0692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8551 -18.6649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8612 -17.8469 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.0320 -16.2119 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.0318 -15.3947 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5705 -17.4412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2766 -17.8526 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9859 -17.4469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6920 -17.8584 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.9893 -16.6297 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.6843 -18.6721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3863 -19.0835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0981 -18.6812 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.1033 -17.8631 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3969 -17.4472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8026 -19.0954 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7938 -19.9108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4975 -20.3248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2093 -19.9217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2131 -19.1003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5089 -18.6900 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0822 -20.3126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 6 1 0
5 3 1 0
3 4 2 0
4 1 1 0
5 6 2 0
5 10 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
1 11 1 0
11 12 1 0
10 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
15 17 2 0
16 18 1 0
16 22 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
20 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 23 1 0
24 29 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 393.53Molecular Weight (Monoisotopic): 393.2416AlogP: 3.50#Rotatable Bonds: 5Polar Surface Area: 36.02Molecular Species: NEUTRALHBA: 4HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 5.36CX LogP: 4.02CX LogD: 4.01Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.78Np Likeness Score: -1.51
References 1. Huang YM, Alharbi NS, Sun B, Shantharam CS, Rakesh KP, Qin HL.. (2019) Synthetic routes and structure-activity relationships (SAR) of anti-HIV agents: A key review., 181 [PMID:31401538 ] [10.1016/j.ejmech.2019.111566 ]